Orphazyme board on CEO changes: She had an old-fashioned management style

On Thursday, the biotech firm Orphazyme announced that the CEO Kim Stratton would no longer be working at the firm after serving for just one year and two months, but she was not fired.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app